Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
133 studies found for:    Open Studies | "Thyroid Neoplasms"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Thyroid Neoplasms"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting An Observational Study in Differentiated Thyroid Cancer Which is Radioactive Iodine (RAI) Refractory to Assess the Use of Multikinase Inhibitors
Condition: Thyroid Neoplasms
Interventions: Drug: Sorafenib (Nexavar, BAY43-9006);   Drug: Other Multikinase inhibitors
2 Recruiting Minimize Radioactive Iodine Ablation Of Remnant Thyroid in Differentiated Thyroid Cancer
Condition: Thyroid Neoplasms
Interventions: Drug: I-131;   Drug: I-125
3 Recruiting Institut Paoli Calmettes Thyroid Cancer Database
Condition: Thyroid Neoplasms
Intervention: Other: Data collection
4 Recruiting Post-marketing Surveillance of Lenvatinib Mesylate (Lenvima Capsule) in Patients With Unresectable Thyroid Cancer (Study LEN01T)
Condition: Thyroid Neoplasms
Intervention: Drug: Lenvatinib
5 Recruiting Assessment of Quality of Life After Adjunct Radioiodine Therapy in Patients With Differentiated Thyroid Cancer
Condition: Thyroid Neoplasms
Intervention:
6 Recruiting Safety and Efficacy of Sorafenib in Patients With Advanced Thyroid Cancer: a Phase II Clinical Study
Condition: Thyroid Cancer
Intervention: Drug: Sorafenib
7 Recruiting Diagnosing Thyroid Cancer Using a Blood Test
Condition: Differentiated Thyroid Cancer
Intervention:
8 Recruiting Sentinel Lymphnode in Patients With Papillary Thyroid Carcinoma and in Patients With Suspected Thyroid Neoplasia
Conditions: Thyroid Neoplasms;   Thyroid Cancer
Intervention: Procedure: Histological investigation of the SN
9 Recruiting Thyroid Cancer Among Chornobyl Clean-up Workers in Ukraine: Pilot Study
Condition: Thyroid Cancer
Intervention:
10 Recruiting A Phase II Study of MLN0128 in Metastatic Anaplastic Thyroid Cancer
Conditions: Anaplastic Thyroid Cancer;   Thyroid Cancer
Intervention: Drug: MLN0128
11 Recruiting IoN- Is Ablative Radio-iodine Necessary for Low Risk Differentiated Thyroid Cancer Patients
Condition: Thyroid Cancer
Intervention: Radiation: I131 1.1 GBq
12 Recruiting A Study Using Regorafenib as Second or Third Line Therapy in Metastatic Medullary Thyroid Cancer
Condition: Thyroid Cancer
Intervention: Drug: Regorafenib
13 Recruiting Initial Management in Patients With Differentiated Thyroid Cancer in the Real World in China
Condition: Differentiated Thyroid Cancer
Intervention:
14 Recruiting Phase II Study Assessing the Efficacy and Safety of Lenvatinib for Anaplastic Thyroid Cancer
Condition: Anaplastic Thyroid Cancer
Intervention: Drug: Lenvatinib
15 Recruiting The Use of Candy and Honey in Decreasing Salivary Gland Damage Following Radioiodine Therapy for Thyroid Cancer
Condition: Thyroid Cancer
Intervention: Dietary Supplement: thymus honey mouthwash
16 Recruiting Vemurafenib Neoadjuvant Trial in Locally Advanced Thyroid Cancer
Condition: Thyroid Cancer
Interventions: Drug: Vemurafenib (All Groups);   Drug: Vemurafenib (Post Surgery) - Group A + C;   Other: Post Surgery - Group B
17 Recruiting A Study of Two Different Doses of Cabozantinib (XL184) in Progressive, Metastatic Medullary Thyroid Cancer
Condition: Medullary Thyroid Cancer
Interventions: Drug: Cabozantinib (XL184) 140 mg;   Drug: Cabozantinib (XL184) 60 mg;   Drug: Placebo tablet;   Drug: Placebo capsule
18 Recruiting Hereditary Risk Factors for Thyroid Cancer
Condition: Thyroid Cancer
Intervention: Genetic: •Referral to Genetic Counselor, if indicated
19 Recruiting An Imaging Study in Patients With Thyroid Cancer or Head and Neck Cancer With Pertechnetate Made in a Cyclotron (C-PERT)
Conditions: Thyroid Neoplasms;   Head and Neck Neoplasms
Interventions: Drug: C-PERT;   Drug: G-PERT
20 Recruiting A Phase II Trial of Cabozantinib for the Treatment of Radioiodine (RAI)-Refractory Differentiated Thyroid Carcinoma (DTC) in the First-line Setting
Conditions: Differentiated Thyroid Cancer (DTC);   Poorly Differentiated Thyroid Cancer
Intervention: Drug: Cabozantinib

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.